# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Demyelinating Diseases

Hypomyelination
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 541 results.
Preventive Use of COrticosteroids During the Post-Partum in Relapsing MS Patients (COPP-MS)
Status: Recruiting
Last Changed: Oct 03, 2019
First Received: Apr 17, 2019
Disease(s): Multiple Sclerosis
Locations: Hôpital LAENNEC, Saint Herblain, Nantes, France
CHU Lyon, Lyon, France
Hôpital Pasteur 2 - CHU Nice, Nice, France
CHU Rennes, Rennes, France
CHU Strasbourg, Strasbourg, France
... and 1 other locations.
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Status: Recruiting
Last Changed: Sep 14, 2020
First Received: Nov 20, 2008
Disease(s): Central Nervous System Disease, Multiple Sclerosis
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
My MS Toolkit + Coaching: A Guided Web-based Symptom Self-Management Program for People With MS
Status: Not yet recruiting
Last Changed: Sep 17, 2020
First Received: Sep 17, 2020
Disease(s): Multiple Sclerosis
Intervention(s): My MS Toolkit
Locations: The University of Michigan, Ann Arbor, Michigan, United States
A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy
Status: Recruiting
Last Changed: Sep 14, 2020
First Received: Dec 11, 2018
Disease(s): Metachromatic Leukodystrophy (MLD)
Intervention(s): SHP611
Locations: Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
Mayo Clinic - PPDS, Rochester, Minnesota, United States
New York University Langone Medical Center, New York, New York, United States
... and 17 other locations.
Preventing Job Loss Using Acceptance and Commitment Therapy in Vocational Rehabilitation
Status: Recruiting
Last Changed: Aug 17, 2020
First Received: Aug 17, 2020
Disease(s): Multiple Sclerosis
Intervention(s): Ready for MS
Locations: Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom
Waking Hypnosis in the Treatment of MS-related Fatigue
Status: Recruiting
Last Changed: Jun 17, 2020
First Received: Jun 12, 2020
Disease(s): Multiple Sclerosis
Intervention(s): Active-Alert Hypnosis, Traditional Hypnosis
Locations: University of Washington, Seattle, Washington, United States
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
Status: Recruiting
Last Changed: Aug 26, 2020
First Received: Feb 24, 2020
Disease(s): Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Intervention(s): efgartigimod PH20 SC in stage B, placebo in stage B
Locations: Investigator Site 6, Carlsbad, California, United States
Investigator site 10, Centennial, Colorado, United States
Investigator site 1, Boca Raton, Florida, United States
Investigator Site 3, Maitland, Florida, United States
Investigator site 9, Orlando, Florida, United States
... and 32 other locations.
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
Status: Not yet recruiting
Last Changed: Aug 18, 2020
First Received: Feb 21, 2020
Disease(s): Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Intervention(s): Efgartigimod PH20 SC
Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab
Status: Recruiting
Last Changed: Mar 04, 2020
First Received: Nov 25, 2019
Disease(s): Multiple Sclerosis, Infusion Reaction
Intervention(s): antihistamine
Locations: Providence Neurological Specialties West, Portland, Oregon, United States
A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS
Status: Recruiting
Last Changed: Feb 27, 2020
First Received: Oct 31, 2019
Disease(s): Multiple Sclerosis
Intervention(s): ADSTEP
Locations: Oregon Health and Science University, Portland, Oregon, United States